Recent advances in treatment for narcolepsy

Recent advances in treatment for narcolepsy

Narcolepsy type 1 (NT1) is a chronic orphan disorder, caused by the selective and irreversible loss of hypocretin/orexin (ORX) neurons, by a probable autoimmune process. Little is known about NT2 etiology and prevalence, sharing with NT1 excessive daytime sleepiness (EDS) and dysregulation of rapid...

Full description

Bibliographic Details
Main Authors:	Lucie Barateau, Yves Dauvilliers
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-09-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/1756286419875622

Similar Items

[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia
by: Yves Dauvilliers, et al.
Published: (2017-07-01)

The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I
by: Leila Khajavi, et al.
Published: (2023-11-01)

Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
by: Ikram Ayoub, et al.
Published: (2023-04-01)

Recent advances in narcolepsy
by: Paul Reading
Published: (2016-09-01)

CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome
by: Lucie Barateau, et al.
Published: (2020-06-01)

Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy
by: Sophie eBayard, et al.
Published: (2013-05-01)

Executive control of attention in narcolepsy.
by: Sophie Bayard, et al.
Published: (2012-01-01)

Low vitamin D in narcolepsy with cataplexy.
by: Bertrand Carlander, et al.
Published: (2011-01-01)

Differences in brain morphological findings between narcolepsy with and without cataplexy.
by: Masaki Nakamura, et al.
Published: (2013-01-01)

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
by: Yves A Dauvilliers, et al.
Published: (2014-06-01)

Non-dipping blood pressure profile in narcolepsy with cataplexy.
by: Yves Dauvilliers, et al.
Published: (2012-01-01)

French Language Online Cognitive Behavioral Therapy for Insomnia Disorder: A Randomized Controlled Trial
by: Régis Lopez, et al.
Published: (2019-12-01)

Increased immune complexes of hypocretin autoantibodies in narcolepsy.
by: Aude Deloumeau, et al.
Published: (2010-01-01)

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
by: Hanna M. Ollila, et al.
Published: (2023-05-01)

Diagnosis and treatment of narcolepsy and parasomnias
by: Zhou Junying
Published: (2021-02-01)

Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening
by: Thi-Tuyet Trinh Tran, et al.
Published: (2024-01-01)

Treatment cost of narcolepsy with cataplexy in Central Europe
by: Maresova P, et al.
Published: (2016-11-01)

Update on the treatment of narcolepsy: clinical efficacy of pitolisant
by: Calik MW
Published: (2017-04-01)

Narcolepsy: current treatment options and future approaches
by: Michel Billiard
Published: (2008-06-01)

Successful Treatment of Narcolepsy and Cataplexy: A Review
by: B Lockrane, et al.
Published: (2005-01-01)

Narcolepsy: origins and insertions
by: JMS Pearce
Published: (2023-12-01)

Progress on narcolepsy and anxiety
by: YU Jie⁃yang, et al.
Published: (2023-08-01)

Narcolepsy Along with an Update
by: Kutluhan Yilmaz
Published: (2015-03-01)

Narcolepsy in childhood and adolescence
by: Rubens Reimão, et al.
Published: (1991-09-01)

Patients with narcolepsy in Slovenia
by: Leja Dolenc Grošelj, et al.
Published: (2014-12-01)

Causes of Hypersomnia – Narcolepsy
by: M V Padma Srivastav
Published: (2014-03-01)

Narcolepsy: a review
by: Akintomide GS, et al.
Published: (2011-09-01)

Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis
by: Zhang Z, et al.
Published: (2022-05-01)

Current and Future Treatment Options for Narcolepsy: A Review
by: Jackie Bhattarai, et al.

Cognitive behavioral treatment for narcolepsy: can it complement pharmacotherapy?
by: Hernán Andrés Marín Agudelo, et al.
Published: (2014-03-01)

Treatment paradigms for cataplexy in narcolepsy: past, present, and future
by: Swick TJ
Published: (2015-12-01)

Cardiac Sympathetic Activity differentiates Idiopathic and Symptomatic Rapid Eye Movement Sleep Behaviour Disorder
by: Lucie Barateau, et al.
Published: (2018-05-01)

An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin−/− mice and patients
by: Jian-Sheng Lin, et al.
Published: (2008-04-01)

Narcolepsy and excessive daytime sleepiness
by: Zeman, A, et al.
Published: (2004)

Narcolepsy with cataplexy in monozygotic twins
by: Leonardo I. Goulart, et al.
Published: (2014-03-01)

Narcolepsy – Between the dream and reality
by: Fernando Morgadinho Santos Coelho
Published: (2014-03-01)

Intellectual Abilities of Children with Narcolepsy
by: Marine Thieux, et al.
Published: (2020-12-01)

Narcolepsy and anxiety. Is this association possible?
by: G.M. Ruiz Martinez, et al.
Published: (2021-04-01)

<it>ApoE</it> polymorphisms in narcolepsy
by: Kasten Meike, et al.
Published: (2001-08-01)

Awareness of Sleep and Narcolepsy in Children
by: Rabia Tütüncü Toker, et al.
Published: (2020-06-01)